COLGATE TOTAL Drug Patent Profile

Which patents cover Colgate Total, and when can generic versions of Colgate Total launch?

Colgate Total is a drug marketed by Colgate Palmolive and is included in one NDA.

The generic ingredient in COLGATE TOTAL is sodium fluoride; triclosan. There are one thousand four hundred and seventy-two drug master file entries for this compound. Additional details are available on the sodium fluoride; triclosan profile page.

Summary for COLGATE TOTAL

US Patents:	0
Applicants:	1
NDAs:	1
Raw Ingredient (Bulk) Api Vendors:	5
Clinical Trials:	45
Patent Applications:	3
DailyMed Link:	COLGATE TOTAL at DailyMed

Recent Clinical Trials for COLGATE TOTAL

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
Loma Linda University	PHASE3
Procter and Gamble	PHASE4
University of Sao Paulo	PHASE4

See all COLGATE TOTAL clinical trials

US Patents and Regulatory Information for COLGATE TOTAL

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Colgate Palmolive	COLGATE TOTAL	sodium fluoride; triclosan	PASTE;DENTAL	020231-001	Jul 11, 1997		DISCN	Yes	No

Expired US Patents for COLGATE TOTAL

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Colgate Palmolive	COLGATE TOTAL	sodium fluoride; triclosan	PASTE;DENTAL	020231-001	Jul 11, 1997	5,776,435
Colgate Palmolive	COLGATE TOTAL	sodium fluoride; triclosan	PASTE;DENTAL	020231-001	Jul 11, 1997	4,894,220
Colgate Palmolive	COLGATE TOTAL	sodium fluoride; triclosan	PASTE;DENTAL	020231-001	Jul 11, 1997	5,538,715

International Patents for COLGATE TOTAL

See the table below for patents covering COLGATE TOTAL around the world.

Country	Patent Number	Title	Estimated Expiration
Mexico	173741	MEJORAS A COMPOSICION ORAL ANTIBACTERIAL Y ANTIPLACA
Ireland	930007
Hungary	T52695

Supplementary Protection Certificates for COLGATE TOTAL

Patent Number	Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
2563920	CR 2019 00001	Denmark		PRODUCT NAME: INOTERSEN AND SALT THEREOF, INCLUDING SODIUM SALTS; REG. NO/DATE: EU/1/18/1296 20180710
0290047	SPC/GB97/078	United Kingdom		PRODUCT NAME: MANGAFODIPIR AND PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF, IN PARTICULAR MANGAFODIPIR TRISODIUM; REGISTERED: UK EU/1/97/040/001 19970522; UK EU/1/97/040/002 19970522
0579826	02C0041	France		PRODUCT NAME: ERTAPENEM SODIUM; REGISTRATION NO/DATE: EU/1/02/216/001 20020418

Market Dynamics and Financial Trajectory for Colgate Total: An Industry Overview

Last updated: July 29, 2025

Introduction

Colgate Total, a prominent product within the oral health segment, represents a notable case in the pharmaceutical and consumer goods markets due to its unique positioning and innovation. Originally launched by Colgate-Palmolive, Colgate Total’s embedded antibacterial properties, achieved through the inclusion of triclosan, distinguished it from traditional toothpastes. Its evolution, market performance, and future prospects mirror broader trends within oral care, antibacterial pharmaceuticals, and consumer health products.

This analysis delineates the key market drivers, competitive landscape, regulatory influences, and financial trajectory shaping Colgate Total’s position, providing strategic insights relevant to stakeholders and industry participants.

---

Market Drivers and Demand Dynamics

The oral care segment continues to exhibit steady growth, driven by increasing consumer awareness about dental hygiene and rising prevalence of periodontal diseases. The global oral health market is projected to reach approximately USD 37 billion by 2025, expanding at a compound annual growth rate (CAGR) of around 4-5%. [1]

Within this landscape, consumer preference is shifting toward products with evidence-based benefits, including antibacterial formulations offering superior plaque and gingivitis control. Colgate Total's formulation, containing triclosan (later phased out in some markets due to safety concerns), aligned well with these consumer trends early on. The product’s reputation for comprehensive oral health benefits facilitated its rapid adoption, especially in North America and parts of Europe.

Furthermore, growing aging populations and increasing rates of oral diseases in emerging markets fuel demand — particularly in developing economies where dental healthcare infrastructure is improving. Urbanization and rising disposable incomes bolster consumption of premium oral care products, favoring brands like Colgate Total that emphasize scientific validation.

Regulatory and Safety Considerations

Regulatory scrutiny significantly influences market dynamics. Concerns surrounding triclosan’s safety profile, including potential endocrine disruption and antibiotic resistance, have prompted regulatory agencies like the FDA to reevaluate its approval status. The FDA, in 2016, issued a final rule restricting triclosan-containing products in over-the-counter antiseptic wash products, leading to phased discontinuation in some regions. [2]

This regulatory shift compelled Colgate-Palmolive to reformulate or withdraw certain variants of Colgate Total, impacting product availability and sales. Nonetheless, the core antibacterial concept remains relevant, with newer formulations focusing on alternative active ingredients with safer profiles.

---

Competitive Landscape

The oral care market features formidable competitors such as Procter & Gamble, Unilever, GlaxoSmithKline, and local entrants in emerging markets. Market leadership is often determined by brand recognition, product efficacy, and regulatory positioning.

Colgate Total has faced competition from traditional fluoride toothpastes and natural/organic alternatives, which appeal to health-conscious consumers wary of synthetic chemicals. Additionally, the advent of mouthwashes, dental devices, and innovative delivery systems expands the competitive spectrum.

Emerging technological trends include the integration of nanotechnology for enhanced antibacterial activity and personalized oral health solutions, shaping the future product pipeline.

Innovation and R&D Impact

Colgate-Palmolive invests significantly in R&D, aiming to develop formulations compliant with evolving regulations while maintaining efficacy. The repositioning of Colgate Total as a triclosan-free product with alternative antibacterial agents exemplifies strategic adaptation.

Anticipated innovations include enzyme-based formulations, bioactive materials, and digital oral health monitoring tools, promising diversified revenue streams and enhanced consumer engagement.

---

Financial Trajectory and Market Performance

Historical Sales Trends

Prior to regulatory restrictions, Colgate Total consistently maintained robust sales, driven by its comprehensive health claims and broad distribution. In the U.S., sales peaked in the early 2010s but declined sharply after triclosan-related regulatory actions around 2016.

Global market share estimates suggest that Colgate Total once accounted for 15-20% of Colgate-Palmolive's oral care segment revenue. Post-regulation, the company shifted focus toward reformulated variants and other segments like whitening and cavity protection, partially offsetting declines.

Revenue Impact

Financial reports indicate a temporary dent in revenue attributable to the reformulation and withdrawal of certain Colgate Total products. Nonetheless, the company’s diversified portfolio and global scale mitigated long-term impact. In 2022, Colgate-Palmolive’s oral care division generated approximately USD 8 billion, with the reformulated Colgate Total regaining some market traction in targeted segments.

Future Outlook

The future financial trajectory hinges on several key factors:

• Reformulation Success: Development of triclosan-free formulations with proven efficacy can restore consumer confidence and sales.
• Market Re-entry Strategies: Reintroduction of Colgate Total in regions where regulatory hurdles are addressed, emphasizing safety and efficacy.
• Innovation Adoption: Investing in next-generation oral health technologies can differentiate offerings and sustain growth.
• Consumer Trends: Growing preference for "clean-label" and natural products may pose challenges but also opportunities for novel formulations.

Emerging Markets and Growth Opportunities

Emerging markets, notably in Asia-Pacific and Latin America, display high-growth potential owing to demographic trends and improving healthcare awareness. Local partnerships and tailored marketing strategies will be critical in capturing market share.

---

Regulatory and Patent Landscape

Patent protection for active ingredients and formulations remains critical. The patent life for key formulations influences market exclusivity periods; however, patent expirations can introduce generic competition, affecting pricing power.

Regulatory agencies' evolving stance necessitates proactive compliance strategies. Recent patent expirations and regulatory restrictions incentivize the development of innovative, patentable formulations that address safety concerns.

---

Strategic Implications for Stakeholders

For pharmaceutical and consumer goods companies, continued investment in R&D, strategic patent filings, and regulatory navigation are vital. Marketing efforts should highlight scientifically validated benefits, safety profiles, and innovative features to differentiate products amid fierce competition.

Investors must monitor regulatory developments, product reformulation success, and market acceptance to refine risk assessments and growth projections.

---

Key Takeaways

• Market机会: Accelerated demand for antibacterial oral care products, especially in emerging markets, offers growth avenues for reformulated Colgate Total variants.
• Regulatory Risks: Triclosan bans and safety concerns necessitate innovation and regulatory compliance, impacting product lifecycle and revenue.
• Innovation is Key: Exploring alternative antibacterial agents and integrating digital health solutions can sustain competitiveness.
• Market Re-entry: Strategic reintroduction in markets with favorable regulatory evolution can revive sales.
• Consumer Preferences: Increasing demand for natural, safe, and transparent products requires adaptation in formulation and branding strategies.

---

FAQs

1. How has regulatory action affected Colgate Total’s market presence?
Regulatory bans, particularly in the U.S. and EU, led to the withdrawal or reformulation of Colgate Total products containing triclosan. This temporarily constrained sales but prompted innovation and reformulation efforts to regain market share.

2. What are the primary competitors to Colgate Total in the oral care segment?
Major competitors include Procter & Gamble’s Crest line, Unilever’s Close-Up, GlaxoSmithKline, and emerging natural or organic brands, all vying for market share with formulations emphasizing efficacy, safety, and natural ingredients.

3. What future innovations could influence Colgate Total’s trajectory?
Advances in nanotechnology, enzyme-based formulations, bioactive materials, and integration of digital oral health monitoring devices are poised to shape future product offerings.

4. How significant is the emerging markets’ role in Colgate Total’s future growth?
Emerging markets remain crucial due to their high population growth, rising incomes, and expanding oral healthcare awareness, offering substantial growth opportunities with localized marketing strategies.

5. Will the reformulated Colgate Total succeed in recapturing consumer confidence?
Success depends on transparent communication about safety, proven efficacy, and adherence to regulatory standards. Investment in marketing and innovation will be pivotal.

---

References

[1] MarketsandMarkets. (2021). Oral Care Market - Global Forecast to 2025.
[2] U.S. Food and Drug Administration. (2016). Final Rule on Triclosan in OTC Antiseptic Wash Products.